Special drug communication teleconference. August 7, 1992.
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D016589:Astemizole / Q000009:adverse effects* / Q000494:pharmacology; D000075202:Contraindications; D004344:Drug Incompatibility; D004347:Drug Interactions; D004562:Electrocardiography / Q000187:drug effects; D006801:Humans; D007654:Ketoconazole / Q000494:pharmacology*; D008107:Liver Diseases; D018942:Macrolides; D016593:Terfenadine / Q000009:adverse effects / Q000494:pharmacology; D014481:United States; D014486:United States Food and Drug Administration
D000900:Anti-Bacterial Agents; D018942:Macrolides; D016593:Terfenadine; D016589:Astemizole; D007654:Ketoconazole